ATE130869T1 - Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen. - Google Patents

Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.

Info

Publication number
ATE130869T1
ATE130869T1 AT92400858T AT92400858T ATE130869T1 AT E130869 T1 ATE130869 T1 AT E130869T1 AT 92400858 T AT92400858 T AT 92400858T AT 92400858 T AT92400858 T AT 92400858T AT E130869 T1 ATE130869 T1 AT E130869T1
Authority
AT
Austria
Prior art keywords
protein
cytokine
microorganisms
type activity
recombinant dna
Prior art date
Application number
AT92400858T
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Assiscle-Avignonet
Jean-Claude Guillemot
Pechdavid De
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE130869T1 publication Critical patent/ATE130869T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
AT92400858T 1991-03-29 1992-03-27 Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen. ATE130869T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.

Publications (1)

Publication Number Publication Date
ATE130869T1 true ATE130869T1 (de) 1995-12-15

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92400858T ATE130869T1 (de) 1991-03-29 1992-03-27 Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.

Country Status (14)

Country Link
US (1) US5652123A (de)
EP (1) EP0506574B1 (de)
JP (1) JP2865423B2 (de)
AT (1) ATE130869T1 (de)
CA (1) CA2083826C (de)
DE (2) DE506574T1 (de)
DK (1) DK0506574T3 (de)
ES (1) ES2054601T3 (de)
GR (2) GR940300052T1 (de)
HK (1) HK1007435A1 (de)
HU (2) HU217099B (de)
IE (1) IE72165B1 (de)
MD (1) MD1652G2 (de)
WO (1) WO1992017586A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
WO1996024665A1 (en) * 1995-02-10 1996-08-15 Novo Nordisk A/S Bacillus proteases
CN1094975C (zh) * 1995-02-10 2002-11-27 诺沃奇梅兹有限公司 芽胞杆菌属蛋白酶
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
EP1141286B1 (de) 1998-12-14 2006-10-18 Genetics Institute, LLC Cytokinrezeptor-kette
AU2001253282A1 (en) * 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
FI3718564T3 (fi) 2003-12-23 2023-12-15 Genentech Inc Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
DE602005025525D1 (de) 2004-11-17 2011-02-03 Amgen Inc Vollständige humane monoklonale antikörper gegen il-13
US20080044420A1 (en) * 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
JP2009510046A (ja) 2005-09-30 2009-03-12 メドイミューン・リミテッド インターロイキン−１３抗体組成物
KR101676269B1 (ko) * 2006-09-08 2016-11-15 애브비 바하마스 리미티드 인터루킨-13 결합 단백질
TW200848429A (en) * 2007-04-23 2008-12-16 Wyeth Corp Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
BRPI0917370A2 (pt) * 2008-08-20 2015-11-17 Centocor Ortho Biotech Inc anticorpos anti-il-13 manipulados, composições, métodos e usos.
GB0904214D0 (en) * 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) * 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
NZ756750A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
WO2015038884A2 (en) 2013-09-13 2015-03-19 Genentech, Inc. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
EP0506574A1 (de) 1992-09-30
ES2054601T1 (es) 1994-08-16
US5652123A (en) 1997-07-29
JPH06500567A (ja) 1994-01-20
HU9203753D0 (en) 1993-03-29
IE72165B1 (en) 1997-03-26
DE69206301T2 (de) 1996-06-13
CA2083826C (en) 1999-04-27
DK0506574T3 (da) 1996-04-09
GR940300052T1 (en) 1994-08-31
JP2865423B2 (ja) 1999-03-08
GR3019043T3 (en) 1996-05-31
HK1007435A1 (en) 1999-04-09
HUT68162A (en) 1995-05-29
MD1652G2 (ro) 2001-12-31
ES2054601T3 (es) 1996-04-01
MD1652F2 (en) 2001-04-30
DE506574T1 (de) 1994-11-17
CA2083826A1 (en) 1992-09-30
EP0506574B1 (de) 1995-11-29
HU217099B (hu) 1999-11-29
WO1992017586A1 (fr) 1992-10-15
DE69206301D1 (de) 1996-01-11
MD970099A (en) 1998-04-30
IE921016A1 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
ATE130869T1 (de) Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
UA84666C2 (ru) ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
ATE358725T1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
ATE73492T1 (de) Dns die eine sequenz enthalten die fuer ein kristallprotein oder ein polypeptid mit insektiziden eigenschaften kodiert, mit solcher dns transformierte mikroorganismen und zusammensetzungen die diese kristallproteine, polypeptide oder mikroorganismen enthalt.
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
DE69231940D1 (de) Rekombinant DNS kodierend für eine Endochitinase
ATE397662T1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
CA2253006A1 (en) .beta.-carotene hydroxylase gene
DE60143561D1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
PT816504E (pt) Acetil-hidrolase para o factor activador das plaquetas, e seu gene
EP0206200A3 (en) Human cholinesterase-type proteins and their production
AU1141695A (en) Interferon-alpha/beta binding protein, its preparation and use
DE69828902D1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
ATE241698T1 (de) Hst-2 mutein, dafür kodierende dns und herstellung
AU5964398A (en) Novel mouse cxc chemokine receptor
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
EP1314785A4 (de) Unter salzstress erhöhte expression aufweisende nukleinsäuren und proteine
ATE71656T1 (de) Fuer kolonie stimulierenden faktor kodierende dns, dadurch kodiertes peptid, diese dns enthaltende vektoren und transformierte wirte und herstellung derselben.
IT1262997B (it) Composto proteico e sequenze nucleotidiche codificanti per esso.
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
WO1999060117A3 (fr) Polypeptide prax-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification